Malformations in the offspring of women with thyroid cancer treated with radioiodine for the ablation of thyroid remnants

Arquivos Brasileiros de Endocrinologia e Metabologia

Volumn 50, Issue 5, 2006, Pages 930-933

  Souza Do Rosário, Pedro Weslley ^a,c   Barroso, Álvaro Luís ^b   Lamego Rezende, Leonardo ^b   Lanza Padrão, Eduardo ^b   Ribeiro Borges, Michelle A ^a   Purisch, Saulo ^a  

^a Department of Thyroid Endocrinology and Metabolism Service ^*  (Brazil)

^b Nuclear Medicine Service   (Brazil)

^c Centro de Estudos e Pesquisa Clínica de Endocrinologia e Metabologia CEPCEM   (Brazil)

Author keywords

Malformations; Radioiodine; Thyroid cancer

Indexed keywords

RADIOACTIVE IODINE;

ARTICLE; CARCINOMA; CHEMICALLY INDUCED DISORDER; CONGENITAL MALFORMATION; FEMALE; HUMAN; NEWBORN; OVARY; PREGNANCY; PREGNANCY COMPLICATION; PREGNANCY OUTCOME; PREMATURITY; RADIATION EXPOSURE; RETROSPECTIVE STUDY; SPONTANEOUS ABORTION; THYROID TUMOR; THYROIDECTOMY;

ABNORMALITIES, DRUG-INDUCED; ABORTION, SPONTANEOUS; CARCINOMA; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; IODINE RADIOISOTOPES; OVARY; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; RETROSPECTIVE STUDIES; THYROID NEOPLASMS; THYROIDECTOMY;

EID: 33845746642     PISSN: 00042730     EISSN: 16779487     Source Type: Journal    
DOI: 10.1590/S0004-27302006000500016     Document Type: Article

References (14)

1. Schlumberger MJ. Medical progress - papillary and follicular thyroid carcinoma. N Engl J Med 1998;338:297-306.
2. Maxon III HR. The role of I-131 in the treatment of thyroid cancer. Thyroid Today 1993;16:1-9.
3. Raymond JP, Izembart M, Marliac V, Dagousset F, Merceron RE, Vulpillat M, et al. Temporary ovarian failure in thyroid cancer patients after thyroid remnant ablation with radioactive iodine. J Clin Endocrinol Metab 1989;69:186-90.
4. Vini L, Hyer S, Al-Saadi A, Pratt B, Harmer C. Prognostic for fertility and ovarian function after treatment with radioiodine for thyroid cancer. Postgrad Med J 2002;78:92-3.
5. Souza Rosario PW, Fagundes TA, Fagundes AS, Barroso AL, Lamego Rezende L, Lanza Padrão E, et al. Ovarian function after radioiodine therapy in patients with thyroid cancer. Exp Clin Endocrinol Diabetes 2005;113:331-3.
6. Schlumberger M, Vathaire F, Ceccarelli C, Delisle MJ, Francese C, Couette JE, et al. Exposure to radioactive iodine-131 for scintigraphy or therapy does not preclude pregnancy in thyroid cancer patients. J Nucl Med 1996;37:606-12.
7. Krassas GE. Thyroid disease and female reproduction. Fertil Steril 2000;74:1063-70.
8. Schlumberger M, De Vathaire F, Ceccarelli C, Francese C, Pinchera A, Parmentier C. Outcome of pregnancy in women with thyroid carcinoma. J Endocrinol Invest 1995;18:150-1.
9. Brandão CD, Antonucci J, Correa ND, Corbo R, Vaisman M. Radioiodine therapy effects on offspring of patients with differentiated thyroid carcinoma. Radiol Bras 2004;37:51-5.
10. Lin JD, Wang HS, Weng HF, Kao PF. Outcome of pregnancy after radioactive iodine treatment for well-differentiated thyroid carcinomas. J Endocrinol Invest 1998;21:662-7.
11. Dottorini ME, Lomuscio G, Mazzucchelli L, Vignati A, Colombo L. Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma. J Nucl Med 1995;36:21-7.
12. Casara D, Rubello D, Saladini G, Piotto A, Pelizzo MR, Girelli ME, et al. Pregnancy after high therapeutic doses of iodine-131 in differentiated thyroid cancer: potential risks and recommendations. Eur J Nucl Med 1993;20:192-4.
13. rd, Smith HS. Radioiodine-131 in the diagnosis and treatment of metastatic well differentiated thyroid cancer. Endocrinol Metab Clin North Am 1990;19:685-718.
14. Lansky S, Franca E, Leal Mdo C. Avoidable perinatal deaths in Belo Horizonte, Minas Gerais, Brazil, 1999. Cad Saúde Pública 2002;18:1389-400.